ME reversed the expressions of intestinal mucosal barrier markers occluding and ZO-1 in the CAC model by repairing the TLR4 cascade and decreasing inflammatory genes, therefore slowing tumor progression (Figure 4). This evidence concerns the gene TJP1 and neoplasm.